Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin-ezetimibe in SLE Atherosclerosis
NCT02548936Phase 1Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Apr 2015
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of simvastatin and ezetimibe in atherosclerosis (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: Change of carotid intima media thickness at 12 months. Status: unknown.
02
Drugs
simvastatinezetimibe
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT02548936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02548936.